Jim Cramer Says Clover Health (CLOV) Was a Good Speculative Pick But Still Prefers UnitedHealth and CVS

Clover Health Investments, Corp. (NASDAQ:CLOV) was among the stocks on Jim Cramer’s radar on Mad Money, as he advised investors to care about where a stock is going, not where it has been. A caller referenced Cramer’s previous comment, calling it speculative, and noted that the company reported GAAP profitability in Q1 2026 and guided for full-year profitability.

Cramer replied: No, that was good. And you could say that I was not bullish enough about it. But see, I’m focused on how great UnitedHealth is and how great CVS is.

But yeah, as a spec, that one was right, that one was right, but I like mine for the long haul. A stock market data. Photo by AlphaTradeZone on Pexels Clover Health Investments, Corp.

(NASDAQ:CLOV) offers preferred provider organization and health maintenance organization Medicare Advantage plans to eligible individuals. The company also provides physicians with a software platform, Clover Assistant, to support the detection, identification, and management of chronic diseases. A caller asked about the company’s stock during the May 29 episode, and Cramer responded: Well, it’s good, but remember, the quarter wasn’t good, the quarter was not good.

So you’re in pure spec mode there. The revenues were okay, but the earnings were not there. So take it with a grain of salt that it’s moved up because it was not a great quarter.

While we acknowledge the potential of CLOV as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years Disclosure: None.

Follow Insider Monkey on Google News. Clover Health Investments, Corp. (NASDAQ:CLOV) was among the stocks on Jim Cramer’s radar on Mad Money, as he advised investors to care about where a stock is going, not where it has been.

A caller referenced Cramer’s previous comment, calling it speculative, and noted that the company reported GAAP profitability in Q1 2026 and guided for full-year profitability. Cramer replied: No, that was good. And you could say that I was not bullish enough about it.

But see, I’m focused on how great UnitedHealth is and how great CVS is. But yeah, as a spec, that one was right, that one was right, but I like mine for the long haul. A stock market data.

Photo by AlphaTradeZone on Pexels Clover Health Investments, Corp. (NASDAQ:CLOV) offers preferred provider organization and health maintenance organization Medicare Advantage plans to eligible individuals. The company also provides physicians with a software platform, Clover Assistant, to support the detection, identification, and management of chronic diseases.

A caller asked about the company’s stock during the May 29 episode, and Cramer responded: Well, it’s good, but remember, the quarter wasn’t good, the quarter was not good. So you’re in pure spec mode there. The revenues were okay, but the earnings were not there.

So take it with a grain of salt that it’s moved up because it was not a great quarter. While we acknowledge the potential of CLOV as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years Disclosure: None. Follow Insider Monkey on Google News. Clover Health Investments, Corp.

(NASDAQ:CLOV) was among the stocks on Jim Cramer’s radar on Mad Money, as he advised investors to care about where a stock is going, not where it has been. A caller referenced Cramer’s previous comment, calling it speculative, and noted that the company reported GAAP profitability in Q1 2026 and guided for full-year profitability. Cramer replied: No, that was good.

And you could say that I was not bullish enough about it. But see, I’m focused on how great UnitedHealth is and how great CVS is. But yeah, as a spec, that one was right, that one was right, but I like mine for the long haul.

A stock market data. Photo by AlphaTradeZone on Pexels Clover Health Investments, Corp. (NASDAQ:CLOV) offers preferred provider organization and health maintenance organization Medicare Advantage plans to eligible individuals.

The company also provides physicians with a software platform, Clover Assistant, to support the detection, identification, and management of chronic diseases. A caller asked about the company’s stock during the May 29 episode, and Cramer responded: Well, it’s good, but remember, the quarter wasn’t good, the quarter was not good. So you’re in pure spec mode there.

The revenues were okay, but the earnin